John D Davis

13PUBLICATIONS
40CO-AUTHORS
Optical technologyHaematological tumoursAllergyGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 01, 2026
Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

|Dec 06, 2025
Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.

Marçal Bravo Padros, Daniela J Conrado, Kamal Srinivasan

|Jun 05, 2025
CD20×CD3 Bispecific Antibodies in B-NHL: A Review of Translational Science, Pharmacokinetics, Pharmacodynamics, and Dose Strategy in Clinical Research.

|Dec 09, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer.

Min Zhu, Priyanka Madia, Alison Crawford

|Jul 31, 2024
Dupilumab: Mechanism of action, clinical, and translational science.

Marc R McCann, Matthew P Kosloski, Christine Xu

|Jul 30, 2024
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials.

Matthew P Kosloski, Emma Guttman-Yassky, Michael J Cork

Pageof 3

Frequent Collaborators

3 joint publications

Min Zhu

3 joint publications

Matthew P Kosloski

2 joint publications

Marçal Bravo Padros

2 joint publications

Samit Ganguly